• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PARK2 通过激活 NF-κB 通路诱导破骨细胞生成。

PARK2 Induces Osteoclastogenesis through Activation of the NF-κB Pathway.

机构信息

Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute (DRI), School of Dentistry, Seoul National University, Seoul 03080, Korea.

出版信息

Mol Cells. 2022 Oct 31;45(10):749-760. doi: 10.14348/molcells.2022.0058. Epub 2022 Aug 29.

DOI:10.14348/molcells.2022.0058
PMID:36047447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9589368/
Abstract

Osteoclast generation from monocyte/macrophage lineage precursor cells needs to be tightly regulated to maintain bone homeostasis and is frequently over-activated in inflammatory conditions. PARK2, a protein associated with Parkinson's disease, plays an important role in mitophagy via its ubiquitin ligase function. In this study, we investigated whether PARK2 is involved in osteoclastogenesis. PARK2 expression was found to be increased during the receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast differentiation. PARK2 gene silencing with siRNA significantly reduced osteoclastogenesis induced by RANKL, LPS (lipopolysaccharide), TNFα (tumor necrosis factor α), and IL-1β (interleukin-1β). On the other hand, overexpression of PARK2 promoted osteoclastogenesis. This regulation of osteoclastogenesis by PARK2 was mediated by IKK (inhibitory κB kinase) and NF-κB activation while MAPK (mitogen-activated protein kinases) activation was not involved. Additionally, administration of PARK2 siRNA significantly reduced osteoclastogenesis and bone loss in an model of inflammatory bone erosion. Taken together, this study establishes a novel role for PARK2 as a positive regulator in osteoclast differentiation and inflammatory bone destruction.

摘要

破骨细胞由单核细胞/巨噬细胞系前体细胞生成,其生成需要受到严格调控,以维持骨内稳态,而在炎症条件下通常会过度激活。PARK2 是一种与帕金森病相关的蛋白,其通过泛素连接酶功能在细胞自噬中发挥重要作用。在本研究中,我们研究了 PARK2 是否参与破骨细胞生成。研究发现,在核因子-κB 配体(RANKL)诱导的破骨细胞分化过程中,PARK2 的表达增加。用 siRNA 沉默 PARK2 基因可显著减少由 RANKL、LPS(脂多糖)、TNFα(肿瘤坏死因子 α)和 IL-1β(白细胞介素-1β)诱导的破骨细胞生成。另一方面,过表达 PARK2 可促进破骨细胞生成。PARK2 对破骨细胞生成的这种调节是通过 IKK(抑制κB 激酶)和 NF-κB 激活介导的,而 MAPK(丝裂原活化蛋白激酶)激活则不参与。此外,给予 PARK2 siRNA 可显著减少炎症性骨侵蚀模型中的破骨细胞生成和骨丢失。综上所述,本研究确立了 PARK2 作为破骨细胞分化和炎症性骨破坏的正向调节因子的新作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/92eaebb39393/molce-45-10-749-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/a54b02fcd0c7/molce-45-10-749-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/d3ffdd13b8bd/molce-45-10-749-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/dfbc9bdc6db2/molce-45-10-749-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/8e7b602c5e20/molce-45-10-749-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/145674969d63/molce-45-10-749-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/a4b534991de7/molce-45-10-749-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/92eaebb39393/molce-45-10-749-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/a54b02fcd0c7/molce-45-10-749-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/d3ffdd13b8bd/molce-45-10-749-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/dfbc9bdc6db2/molce-45-10-749-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/8e7b602c5e20/molce-45-10-749-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/145674969d63/molce-45-10-749-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/a4b534991de7/molce-45-10-749-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a633/9589368/92eaebb39393/molce-45-10-749-f7.jpg

相似文献

1
PARK2 Induces Osteoclastogenesis through Activation of the NF-κB Pathway.PARK2 通过激活 NF-κB 通路诱导破骨细胞生成。
Mol Cells. 2022 Oct 31;45(10):749-760. doi: 10.14348/molcells.2022.0058. Epub 2022 Aug 29.
2
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
3
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.马粟酸通过调节 RANKL 介导的 NF-κB 和 MAPK 信号通路抑制破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2011 Mar;26(3):644-56. doi: 10.1002/jbmr.242.
4
Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis.淫羊藿苷通过抑制 MAPKs/NF-κB 调控的 HIF-1α 和 PGE(2)合成来抑制破骨细胞分化和骨吸收。
Phytomedicine. 2011 Jan 15;18(2-3):176-85. doi: 10.1016/j.phymed.2010.04.003.
5
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.倍半萜内酯小白菊内酯通过抑制核因子κB活性来阻断脂多糖诱导的骨溶解。
J Bone Miner Res. 2004 Nov;19(11):1905-16. doi: 10.1359/JBMR.040919. Epub 2004 Sep 27.
6
12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.12-O-十四酰佛波醇-13-乙酸酯(TPA)通过抑制RANKL诱导的NF-κB活化来抑制破骨细胞生成。
J Bone Miner Res. 2003 Dec;18(12):2159-68. doi: 10.1359/jbmr.2003.18.12.2159.
7
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages.蜂毒肽通过下调RANKL-RANK信号通路以及抑制小鼠巨噬细胞中的白细胞介素-1β来抑制破骨细胞形成。
Int J Mol Med. 2017 Mar;39(3):539-548. doi: 10.3892/ijmm.2017.2876. Epub 2017 Feb 3.
8
Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.锝-99 标记的亚甲基二膦酸盐抑制核因子-κB 受体激活配体诱导的破骨细胞生成。
Clin Exp Pharmacol Physiol. 2012 Oct;39(10):886-93. doi: 10.1111/j.1440-1681.2012.12006.x.
9
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.共轭亚油酸通过调节RANKL信号通路抑制RAW264.7细胞的破骨细胞分化。
J Lipid Res. 2006 Aug;47(8):1739-48. doi: 10.1194/jlr.M600151-JLR200. Epub 2006 May 15.
10
Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.姜黄素抑制 RANKL 诱导的破骨细胞生成及其作用机制。
J Cell Physiol. 2019 May;234(5):7498-7509. doi: 10.1002/jcp.27511. Epub 2018 Nov 23.

引用本文的文献

1
PARK2 as a susceptibility factor for nontuberculous mycobacterial pulmonary disease.PARK2 作为非结核分枝杆菌肺病的易患因素。
Respir Res. 2024 Aug 14;25(1):310. doi: 10.1186/s12931-024-02946-4.
2
Advances in the Pathogenesis of Steroid-Associated Osteonecrosis of the Femoral Head.类固醇相关性股骨头坏死发病机制的研究进展。
Biomolecules. 2024 Jun 6;14(6):667. doi: 10.3390/biom14060667.
3
Diabetic Rats Induced Using a High-Fat Diet and Low-Dose Streptozotocin Treatment Exhibit Gut Microbiota Dysbiosis and Osteoporotic Bone Pathologies.

本文引用的文献

1
Macrophage Polarization and the Osteoimmunology of Periprosthetic Osteolysis.巨噬细胞极化与人工关节周围骨溶解的骨免疫学
Curr Osteoporos Rep. 2022 Feb;20(1):43-52. doi: 10.1007/s11914-022-00720-3. Epub 2022 Feb 8.
2
Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease.线粒体质量的多任务守护者:Parkin 功能与帕金森病。
Transl Neurodegener. 2021 Jan 20;10(1):5. doi: 10.1186/s40035-020-00229-8.
3
Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.评估单等位基因 PRKN 突变与帕金森病风险的关系。
采用高脂饮食和低剂量链脲佐菌素治疗诱导的糖尿病大鼠表现出肠道微生物群失调和骨质疏松性骨病理。
Nutrients. 2024 Apr 19;16(8):1220. doi: 10.3390/nu16081220.
4
Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.NFATc1在类风湿关节炎相关骨破坏中的最新进展:机制与潜在治疗靶点
Mol Med. 2024 Feb 3;30(1):20. doi: 10.1186/s10020-024-00788-w.
5
Avenanthramide-C Shows Potential to Alleviate Gingival Inflammation and Alveolar Bone Loss in Experimental Periodontitis.燕麦酰胺 C 有望缓解实验性牙周炎中的牙龈炎症和牙槽骨丧失。
Mol Cells. 2023 Oct 31;46(10):627-636. doi: 10.14348/molcells.2023.0109. Epub 2023 Aug 29.
6
A computational approach based on weighted gene co-expression network analysis for biomarkers analysis of Parkinson's disease and construction of diagnostic model.一种基于加权基因共表达网络分析的计算方法,用于帕金森病生物标志物分析及诊断模型构建。
Front Comput Neurosci. 2023 Jan 10;16:1095676. doi: 10.3389/fncom.2022.1095676. eCollection 2022.
Hum Mol Genet. 2021 Mar 25;30(1):78-86. doi: 10.1093/hmg/ddaa273.
4
PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.PINK1/PARKIN 信号在神经退行性变和神经炎症中的作用。
Acta Neuropathol Commun. 2020 Nov 9;8(1):189. doi: 10.1186/s40478-020-01062-w.
5
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.E3 泛素连接酶 PARK2 调控 Hippo/YAP 信号通路及食管鳞癌的进展
Theranostics. 2020 Jul 25;10(21):9443-9457. doi: 10.7150/thno.46078. eCollection 2020.
6
Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.自噬依赖性巨噬细胞重编程可防止肾脏纤维化。
JCI Insight. 2019 Dec 5;4(23):132826. doi: 10.1172/jci.insight.132826.
7
Deacylcynaropicrin Inhibits RANKL-Induced Osteoclastogenesis by Inhibiting NF-κB and MAPK and Promoting M2 Polarization of Macrophages.去酰基千里光苦素通过抑制NF-κB和MAPK以及促进巨噬细胞的M2极化来抑制RANKL诱导的破骨细胞生成。
Front Pharmacol. 2019 Jun 7;10:599. doi: 10.3389/fphar.2019.00599. eCollection 2019.
8
Parkin regulates NF-κB by mediating site-specific ubiquitination of RIPK1.Parkin 通过介导 RIPK1 的位点特异性泛素化来调节 NF-κB。
Cell Death Dis. 2018 Jun 28;9(7):732. doi: 10.1038/s41419-018-0770-z.
9
TNF‑α and RANKL promote osteoclastogenesis by upregulating RANK via the NF‑κB pathway.TNF-α 和 RANKL 通过 NF-κB 通路上调 RANK 促进破骨细胞生成。
Mol Med Rep. 2018 May;17(5):6605-6611. doi: 10.3892/mmr.2018.8698. Epub 2018 Mar 7.
10
Regulation of Osteoclast Differentiation by Cytokine Networks.细胞因子网络对破骨细胞分化的调控
Immune Netw. 2018 Feb 7;18(1):e8. doi: 10.4110/in.2018.18.e8. eCollection 2018 Feb.